首页 > 最新文献

Human Gene最新文献

英文 中文
Reciprocal regulation of miR-657 and IL-37 and its association with CTLA-4 dysregulation in Pediatric asthma: Diagnostic implications 儿童哮喘中miR-657和IL-37的相互调节及其与CTLA-4失调的关系:诊断意义
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2026-01-14 DOI: 10.1016/j.humgen.2026.201532
Ghanyia Jasim Shanyoor , Rand Moushtaq Taleb , Rawan Ahmed Nijeeb , Hiba Muneer Abdel Hassan Al-Khafaji , Maryam Qasim Mohammed

Background

Asthma is a chronic inflammatory disease of the airways, in which dysregulation of immune mediators contributes to disease pathogenesis. Interleukin-37 (IL-37) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are key immunoregulatory molecules, while miR-657 has been implicated in modulating IL-37 expression in inflammatory conditions.

Objectives

This study aimed to assess the expression levels of IL-37, CTLA-4, and miR-657 in asthma patients compared with healthy individuals, and to evaluate their diagnostic relevance through Receiver Operating Characteristic (ROC) curve analysis and logistic regression, without the intention of developing a predictive model or examining molecular interactions among these parameters.

Methods

This study included 90 participants, comprising 45 asthma patients and 45 age- and sex-matched healthy controls. Peripheral blood samples were analyzed to measure total IgE (Rate Scattering Turbidimetric Method), IL-37 mRNA expression (qRT-PCR), miR-657 levels (qRT-PCR), and circulating CTLA-4 concentrations (ELISA). Statistical evaluation involved ROC curve analysis to assess diagnostic performance and logistic regression to determine associations with asthma risk.

Results

Compared with healthy controls, asthma patients exhibited significantly lower IL-37 expression (fold change: 0.82 ± 0.2 vs. 1.12 ± 0.4) and reduced serum CTLA-4 concentrations (45.67 ± 19.92 vs. 73.75 ± 26.11 ng/mL), whereas miR-657 expression was significantly increased (fold change: 1.59 ± 0.7 vs. 1.07 ± 0.3). ROC curve analysis demonstrated that IL-37 (AUC = 0.771), CTLA-4 (AUC = 0.807), and miR-657 (AUC = 0.763) possess promising diagnostic accuracy, with substantial sensitivity and specificity. Logistic regression analysis confirmed that decreased IL-37 (OR = 0.11) and CTLA-4 (OR = 0.96), as well as elevated miR-657 (OR = 9.74), were significantly associated with increased asthma risk (overall model AUC = 0.890), supporting their relevance as diagnostic indicators.

Conclusion

The reciprocal regulation of miR-657 and IL-37, alongside diminished CTLA-4, points to a disrupted immunoregulatory axis in asthma. Collectively, these findings highlight the potential utility of miR-657, IL-37, and CTLA-4 as diagnostic signatures for asthma, supporting their relevance in disease assessment and monitoring.
哮喘是一种气道慢性炎症性疾病,其中免疫介质的失调参与了疾病的发病机制。白细胞介素-37 (IL-37)和细胞毒性t淋巴细胞相关蛋白4 (CTLA-4)是关键的免疫调节分子,而miR-657参与调节炎症条件下IL-37的表达。目的本研究旨在评估IL-37、CTLA-4和miR-657在哮喘患者中的表达水平,并通过受试者工作特征(ROC)曲线分析和logistic回归评估其诊断相关性,而无意建立预测模型或检查这些参数之间的分子相互作用。方法本研究纳入90名受试者,包括45名哮喘患者和45名年龄和性别匹配的健康对照。分析外周血样本,测定总IgE(率散射浊度法)、IL-37 mRNA表达(qRT-PCR)、miR-657水平(qRT-PCR)和循环CTLA-4浓度(ELISA)。统计评价包括ROC曲线分析来评估诊断表现和逻辑回归来确定与哮喘风险的关系。结果与健康对照组相比,哮喘患者IL-37表达显著降低(倍数变化:0.82±0.2∶1.12±0.4),血清CTLA-4浓度显著降低(倍数变化:45.67±19.92∶73.75±26.11 ng/mL), miR-657表达显著升高(倍数变化:1.59±0.7∶1.07±0.3)。ROC曲线分析显示,IL-37 (AUC = 0.771)、CTLA-4 (AUC = 0.807)、miR-657 (AUC = 0.763)具有较好的诊断准确性,具有较高的敏感性和特异性。Logistic回归分析证实,IL-37 (OR = 0.11)和CTLA-4 (OR = 0.96)降低以及miR-657 (OR = 9.74)升高与哮喘风险增加显著相关(总模型AUC = 0.890),支持其作为诊断指标的相关性。结论miR-657和IL-37的相互调节,以及CTLA-4的减少,指向哮喘免疫调节轴的破坏。总的来说,这些发现强调了miR-657、IL-37和CTLA-4作为哮喘诊断特征的潜在效用,支持它们在疾病评估和监测中的相关性。
{"title":"Reciprocal regulation of miR-657 and IL-37 and its association with CTLA-4 dysregulation in Pediatric asthma: Diagnostic implications","authors":"Ghanyia Jasim Shanyoor ,&nbsp;Rand Moushtaq Taleb ,&nbsp;Rawan Ahmed Nijeeb ,&nbsp;Hiba Muneer Abdel Hassan Al-Khafaji ,&nbsp;Maryam Qasim Mohammed","doi":"10.1016/j.humgen.2026.201532","DOIUrl":"10.1016/j.humgen.2026.201532","url":null,"abstract":"<div><h3>Background</h3><div>Asthma is a chronic inflammatory disease of the airways, in which dysregulation of immune mediators contributes to disease pathogenesis. Interleukin-37 (IL-37) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are key immunoregulatory molecules, while miR-657 has been implicated in modulating IL-37 expression in inflammatory conditions.</div></div><div><h3>Objectives</h3><div>This study aimed to assess the expression levels of <em>IL-37</em>, CTLA-4, and <em>miR-657</em> in asthma patients compared with healthy individuals, and to evaluate their diagnostic relevance through Receiver Operating Characteristic (ROC) curve analysis and logistic regression, without the intention of developing a predictive model or examining molecular interactions among these parameters.</div></div><div><h3>Methods</h3><div>This study included 90 participants, comprising 45 asthma patients and 45 age- and sex-matched healthy controls. Peripheral blood samples were analyzed to measure total IgE (Rate Scattering Turbidimetric Method), IL-37 mRNA expression (qRT-PCR), miR-657 levels (qRT-PCR), and circulating CTLA-4 concentrations (ELISA). Statistical evaluation involved ROC curve analysis to assess diagnostic performance and logistic regression to determine associations with asthma risk.</div></div><div><h3>Results</h3><div>Compared with healthy controls, asthma patients exhibited significantly lower <em>IL-37</em> expression (fold change: 0.82 ± 0.2 vs. 1.12 ± 0.4) and reduced serum CTLA-4 concentrations (45.67 ± 19.92 vs. 73.75 ± 26.11 ng/mL), whereas <em>miR-657</em> expression was significantly increased (fold change: 1.59 ± 0.7 vs. 1.07 ± 0.3). ROC curve analysis demonstrated that <em>IL-37</em> (AUC = 0.771), CTLA-4 (AUC = 0.807), and <em>miR-657</em> (AUC = 0.763) possess promising diagnostic accuracy, with substantial sensitivity and specificity. Logistic regression analysis confirmed that decreased <em>IL-37</em> (OR = 0.11) and CTLA-4 (OR = 0.96), as well as elevated <em>miR-657</em> (OR = 9.74), were significantly associated with increased asthma risk (overall model AUC = 0.890), supporting their relevance as diagnostic indicators.</div></div><div><h3>Conclusion</h3><div>The reciprocal regulation of miR-657 and IL-37, alongside diminished CTLA-4, points to a disrupted immunoregulatory axis in asthma. Collectively, these findings highlight the potential utility of <em>miR-657</em>, <em>IL-37</em>, and CTLA-4 as diagnostic signatures for asthma, supporting their relevance in disease assessment and monitoring.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201532"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146022690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic polymorphisms associated with type 2 diabetes in Morocco: A systematic literature review 遗传多态性与2型糖尿病在摩洛哥:系统的文献综述
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2026-01-10 DOI: 10.1016/j.humgen.2026.201531
Atmane Ait baha , Zineb Kahli , Hind Idrissi Hassani , Mouna Habbane , Sofia Semlali , Otmane El Brini , Bouchra Benazzouz , Nawal El Ansari , Omar Akhouayri
This systematic literature review (SLR) investigated genetic polymorphisms associated with Type 2 Diabetes Mellitus (T2DM) in the Moroccan population by analyzing original research articles from multiple electronic databases, including PubMed, Scopus, ScienceDirect, Web of Science, and EBSCO. We identified studies that examined 52 genes and 90 single nucleotide polymorphisms. These polymorphisms are distributed across critical genes implicated in T2DM susceptibility. This review revealed several significant genetic associations, with TCF7L2 emerging as the gene most strongly associated with T2DM susceptibility in the Moroccan population. Other important genes identified included CYP11B2, FHL2, ADIPOQ, TNF-A, and IGF2BP2, which were associated with T2DM risk to varying degrees. The analysis revealed the involvement of multiple pathways, including inflammatory processes, insulin secretion, and glucose homeostasis in T2DM pathogenesis. These findings provide a comprehensive overview of the genetic architecture underlying T2DM in the Moroccan population, offering valuable insights for future research and the potential development of personalized therapeutic approaches. This review represents a significant step toward understanding population-specific genetic factors of T2DM and their implications for clinical practice.
本系统文献综述(SLR)通过分析来自多个电子数据库(包括PubMed、Scopus、ScienceDirect、Web of Science和EBSCO)的原始研究文章,调查了摩洛哥人群中与2型糖尿病(T2DM)相关的遗传多态性。我们鉴定了52个基因和90个单核苷酸多态性的研究。这些多态性分布在与T2DM易感性相关的关键基因中。这篇综述揭示了几个重要的遗传关联,其中TCF7L2是与摩洛哥人群中2型糖尿病易感性最密切相关的基因。其他鉴定的重要基因包括CYP11B2、FHL2、ADIPOQ、TNF-A和IGF2BP2,这些基因与T2DM风险有不同程度的关联。分析揭示了T2DM发病机制涉及多种途径,包括炎症过程、胰岛素分泌和葡萄糖稳态。这些发现为摩洛哥人群中T2DM的遗传结构提供了一个全面的概述,为未来的研究和个性化治疗方法的潜在发展提供了有价值的见解。这篇综述是了解2型糖尿病人群特异性遗传因素及其对临床实践意义的重要一步。
{"title":"Genetic polymorphisms associated with type 2 diabetes in Morocco: A systematic literature review","authors":"Atmane Ait baha ,&nbsp;Zineb Kahli ,&nbsp;Hind Idrissi Hassani ,&nbsp;Mouna Habbane ,&nbsp;Sofia Semlali ,&nbsp;Otmane El Brini ,&nbsp;Bouchra Benazzouz ,&nbsp;Nawal El Ansari ,&nbsp;Omar Akhouayri","doi":"10.1016/j.humgen.2026.201531","DOIUrl":"10.1016/j.humgen.2026.201531","url":null,"abstract":"<div><div>This systematic literature review (SLR) investigated genetic polymorphisms associated with Type 2 Diabetes Mellitus (T2DM) in the Moroccan population by analyzing original research articles from multiple electronic databases, including PubMed, Scopus, ScienceDirect, Web of Science, and EBSCO. We identified studies that examined 52 genes and 90 single nucleotide polymorphisms. These polymorphisms are distributed across critical genes implicated in T2DM susceptibility. This review revealed several significant genetic associations, with <em>TCF7L2</em> emerging as the gene most strongly associated with T2DM susceptibility in the Moroccan population. Other important genes identified included <em>CYP11B2</em>, <em>FHL2</em>, <em>ADIPOQ</em>, <em>TNF-A,</em> and <em>IGF2BP2</em>, which were associated with T2DM risk to varying degrees. The analysis revealed the involvement of multiple pathways, including inflammatory processes, insulin secretion, and glucose homeostasis in T2DM pathogenesis. These findings provide a comprehensive overview of the genetic architecture underlying T2DM in the Moroccan population, offering valuable insights for future research and the potential development of personalized therapeutic approaches. This review represents a significant step toward understanding population-specific genetic factors of T2DM and their implications for clinical practice.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201531"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145975980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D receptor gene polymorphisms and the risk of autism spectrum disorder (ASD): A meta-analysis 维生素D受体基因多态性与自闭症谱系障碍(ASD)风险:一项荟萃分析
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2025-11-26 DOI: 10.1016/j.humgen.2025.201517
Ghasem Fakourizad , Alireza Hatami , Saeed Aslani , Mohammad Masoud Eslami , Danyal Imani , Bahman Razi , Tannaz Jamialahmadi , Prashant Kesharwani , Amirhossein Sahebkar
Several investigations have noted to the potential link between Vitamin D Receptor (VDR) gene polymorphisms and autism spectrum disorder (ASD); however, the findings have been controversial. To find a convincing answer, we performed this meta-analysis to identify a reliable understanding for plausible association of VDR gene SNPs and risk of ASD susceptibility. A systematic search was performed to search for relevant studies assessing the association between the Cdx (rs11568820), TaqI (rs731236), FokI (rs2228570), ApaI (rs7975232), and BsmI (rs1544410) SNPs of the VDR gene and susceptibility to ASD released before January 2024. Odd Ratio (OR) and 95 % CI were used to show statistical relationship between the VDR gene SNPs and ASD. In the final analysis 14 studies containing 2023 ASD patients and 2008 healthy individuals were included. The comprehensive analysis revealed that the TaqI variant across all genotypes, and the FokI variant in recessive, allelic, and homozygote genetic models, were associated with an increased risk of ASD. According to the findings of this meta-analysis, TaqI and FokI SNPs play a role in predisposition to ASD; however, because of limitation in sample size and geographical distribution of included studies, findings should be interpreted cautiously.
一些研究已经注意到维生素D受体(VDR)基因多态性与自闭症谱系障碍(ASD)之间的潜在联系;然而,这些发现一直存在争议。为了找到一个令人信服的答案,我们进行了这项荟萃分析,以确定对VDR基因snp与ASD易感性风险之间的可信关联的可靠理解。系统检索2024年1月前发布的VDR基因Cdx (rs11568820)、TaqI (rs731236)、FokI (rs2228570)、ApaI (rs7975232)和BsmI (rs1544410) snp与ASD易感性相关性的相关研究。使用奇数比(OR)和95% CI显示VDR基因snp与ASD之间的统计学关系。在最后的分析中,包括2023名ASD患者和2008名健康个体的14项研究被纳入。综合分析显示,TaqI在所有基因型中的变异,以及FokI在隐性、等位基因和纯合子遗传模型中的变异与ASD风险增加有关。根据本荟萃分析的结果,TaqI和FokI snp在ASD易感性中起作用;然而,由于纳入研究的样本量和地理分布的限制,研究结果应谨慎解释。
{"title":"Vitamin D receptor gene polymorphisms and the risk of autism spectrum disorder (ASD): A meta-analysis","authors":"Ghasem Fakourizad ,&nbsp;Alireza Hatami ,&nbsp;Saeed Aslani ,&nbsp;Mohammad Masoud Eslami ,&nbsp;Danyal Imani ,&nbsp;Bahman Razi ,&nbsp;Tannaz Jamialahmadi ,&nbsp;Prashant Kesharwani ,&nbsp;Amirhossein Sahebkar","doi":"10.1016/j.humgen.2025.201517","DOIUrl":"10.1016/j.humgen.2025.201517","url":null,"abstract":"<div><div>Several investigations have noted to the potential link between <em>Vitamin D Receptor</em> (<em>VDR</em>) gene polymorphisms and autism spectrum disorder (ASD); however, the findings have been controversial. To find a convincing answer, we performed this meta-analysis to identify a reliable understanding for plausible association of <em>VDR</em> gene SNPs and risk of ASD susceptibility. A systematic search was performed to search for relevant studies assessing the association between the Cdx (rs11568820), TaqI (rs731236), <em>Fok</em>I (rs2228570), <em>Apa</em>I (rs7975232), and <em>Bsm</em>I (rs1544410) SNPs of the <em>VDR</em> gene and susceptibility to ASD released before January 2024. Odd Ratio (OR) and 95 % CI were used to show statistical relationship between the <em>VDR</em> gene SNPs and ASD. In the final analysis 14 studies containing 2023 ASD patients and 2008 healthy individuals were included. The comprehensive analysis revealed that the TaqI variant across all genotypes, and the <em>Fok</em>I variant in recessive, allelic, and homozygote genetic models, were associated with an increased risk of ASD. According to the findings of this meta-analysis, TaqI and FokI SNPs play a role in predisposition to ASD; however, because of limitation in sample size and geographical distribution of included studies, findings should be interpreted cautiously.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201517"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145616455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative transcriptomic profiling of differentially expressed genes to identify potential biomarkers and repurposable therapeutic candidates in idiopathic pulmonary fibrosis 差异表达基因的整合转录组学分析,以确定特发性肺纤维化的潜在生物标志物和可重新利用的治疗候选者
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2026-01-13 DOI: 10.1016/j.humgen.2026.201533
Bhavsar Mauli Chirag , Potnuri Vishnu Priyanka , Subhashini
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by irreversible lung scarring with limited therapeutic options, poor prognosis, and high mortality rate. The present study aimed to elucidate the potential diagnostic biomarkers and therapeutic targets for IPF using an integrative bioinformatics and systems biology framework. Differential gene expression analysis of publicly available transcriptomic datasets (GSE199152 and GSE199949) identified key differentially expressed genes (DEGs) involved predominantly in extracellular matrix organization, immune regulation, and fibrotic signaling pathways. Construction of protein–protein interaction (PPI) networks followed by cytoHubba analysis identified five core hub genes (ITGA2, ITGB3, ITGA11, COL1A1, and COL1A2), whose diagnostic potential was evaluated in silico using receiver operating characteristic (ROC) curve analysis. To strengthen the robustness of these biomarker candidates, an independent external dataset (GSE92592) was used for validation, where all five hub genes demonstrated high AUC values, confirming their reproducible diagnostic potential across cohorts. Gene regulatory network analysis highlighted critical transcription factors (SP1, RELA, NFKB1) and microRNAs (miR-29c, miR-21, miR-155, miR-30a) regulating these hub genes, emphasizing the complex transcriptional and post-transcriptional regulation underlying IPF. In parallel, drug repurposing analysis through DrugBank data, ADMET profiling, and molecular docking identified favorable interactions between the hub proteins and both approved (Nintedanib, Pirfenidone) and investigational drugs (Omipalisib, Olitigaltin, Suplatast, Tipelukast). Notably, Omipalisib and Olitigaltin exhibited favorable binding affinities, hydrogen bond interactions, and pharmacokinetic properties, suggesting potential therapeutic value in IPF management. Collectively, this integrative transcriptomics approach provides novel insights into IPF pathogenesis and highlights potential biomarkers and therapeutic candidates that may be further validated experimentally.
特发性肺纤维化(IPF)是一种慢性进行性间质性肺疾病,其特征是不可逆的肺瘢痕形成,治疗选择有限,预后差,死亡率高。本研究旨在利用综合生物信息学和系统生物学框架阐明IPF的潜在诊断生物标志物和治疗靶点。对公开的转录组数据集(GSE199152和GSE199949)进行差异基因表达分析,确定了主要参与细胞外基质组织、免疫调节和纤维化信号通路的关键差异表达基因(deg)。构建蛋白-蛋白相互作用(PPI)网络并进行cytoHubba分析,鉴定出5个核心枢纽基因(ITGA2、ITGB3、ITGA11、COL1A1和COL1A2),并利用受试者工作特征(ROC)曲线分析对其诊断潜力进行计算机评估。为了加强这些候选生物标志物的稳健性,使用了一个独立的外部数据集(GSE92592)进行验证,其中所有五个中心基因都显示出高AUC值,证实了它们在队列中的可重复性诊断潜力。基因调控网络分析强调了关键转录因子(SP1、RELA、NFKB1)和调控这些枢纽基因的microrna (miR-29c、miR-21、miR-155、miR-30a),强调了IPF背后复杂的转录和转录后调控。与此同时,通过DrugBank数据、ADMET分析和分子对接进行的药物再利用分析发现,枢纽蛋白与已批准药物(尼达尼布、吡非尼酮)和研究药物(奥米帕利西布、奥利替高汀、Suplatast、Tipelukast)之间存在有利的相互作用。值得注意的是,Omipalisib和oligigaltin表现出良好的结合亲和力、氢键相互作用和药代动力学特性,这表明它们在IPF治疗中具有潜在的治疗价值。总的来说,这种整合转录组学方法为IPF的发病机制提供了新的见解,并强调了可能进一步实验验证的潜在生物标志物和治疗候选物。
{"title":"Integrative transcriptomic profiling of differentially expressed genes to identify potential biomarkers and repurposable therapeutic candidates in idiopathic pulmonary fibrosis","authors":"Bhavsar Mauli Chirag ,&nbsp;Potnuri Vishnu Priyanka ,&nbsp;Subhashini","doi":"10.1016/j.humgen.2026.201533","DOIUrl":"10.1016/j.humgen.2026.201533","url":null,"abstract":"<div><div>Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by irreversible lung scarring with limited therapeutic options, poor prognosis, and high mortality rate. The present study aimed to elucidate the potential diagnostic biomarkers and therapeutic targets for IPF using an integrative bioinformatics and systems biology framework. Differential gene expression analysis of publicly available transcriptomic datasets (<span><span>GSE199152</span><svg><path></path></svg></span> and <span><span>GSE199949</span><svg><path></path></svg></span>) identified key differentially expressed genes (DEGs) involved predominantly in extracellular matrix organization, immune regulation, and fibrotic signaling pathways. Construction of protein–protein interaction (PPI) networks followed by cytoHubba analysis identified five core hub genes (ITGA2, ITGB3, ITGA11, COL1A1, and COL1A2), whose diagnostic potential was evaluated in silico using receiver operating characteristic (ROC) curve analysis. To strengthen the robustness of these biomarker candidates, an independent external dataset (<span><span>GSE92592</span><svg><path></path></svg></span>) was used for validation, where all five hub genes demonstrated high AUC values, confirming their reproducible diagnostic potential across cohorts. Gene regulatory network analysis highlighted critical transcription factors (SP1, RELA, NFKB1) and microRNAs (miR-29c, miR-21, miR-155, miR-30a) regulating these hub genes, emphasizing the complex transcriptional and post-transcriptional regulation underlying IPF. In parallel, drug repurposing analysis through DrugBank data, ADMET profiling, and molecular docking identified favorable interactions between the hub proteins and both approved (Nintedanib, Pirfenidone) and investigational drugs (Omipalisib, Olitigaltin, Suplatast, Tipelukast). Notably, Omipalisib and Olitigaltin exhibited favorable binding affinities, hydrogen bond interactions, and pharmacokinetic properties, suggesting potential therapeutic value in IPF management. Collectively, this integrative transcriptomics approach provides novel insights into IPF pathogenesis and highlights potential biomarkers and therapeutic candidates that may be further validated experimentally.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201533"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146022688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding rare diseases in Saudi Arabia: A systematic review of available evidence 了解沙特阿拉伯的罕见病:对现有证据的系统审查
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2026-01-24 DOI: 10.1016/j.humgen.2026.201534
Dalal Alkathiry , Mohammed Alabdulaali , Ghali Sayedahmed , Anas Almasud , Nora Althumairi , Guillaume Favier , Abdulelah AlGosaibi , Karam Rachid , Norah AlMousa , Haya Intabli , Mohammed Senitan , Nawfal Aljerian

Introduction

Rare diseases (RDs) are a major public health challenge in high-consanguinity regions like Saudi Arabia. Mostly genetic, chronic, and lacking effective treatment, they often face diagnostic delays and limited care. This study systematically reviews the prevalence, genetic risk factors, and healthcare challenges of RDs in Saudi Arabia.

Methods

A systematic review was conducted following PRISMA 2020 guidelines. Databases searched included MEDLINE (PubMed), Embase, Web of Science, and Scopus (2014–2024). Eligible studies addressed epidemiology, genetic predisposition, or clinical management of RDs in Saudi Arabia. Extracted data covered study design, sample size, disease type, and findings. Study quality was assessed with the Joanna Briggs Institute (JBI) tool.

Results

From 597 records, 25 studies met inclusion. Frequently studied RDs were Duchenne Muscular Dystrophy (DMD), Idiopathic Pulmonary Fibrosis (IPF), Myasthenia Gravis (MG), Granulomatosis with Polyangiitis (GPA), Sickle Cell Disease (SCD), and Spinal Muscular Atrophy (SMA). Across studies, delayed diagnosis, lack of genetic screening, and high economic burden were consistent themes. High consanguinity increased autosomal recessive disorders. Major gaps included limited access to specialized care, advanced therapies, and the absence of a national RD registry.

Conclusions

There is urgent need to expand genetic screening, improve diagnostics, and strengthen RD healthcare services in Saudi Arabia. Establishing registries, raising awareness, and developing cost-effective therapies are critical to improving outcomes and reducing disease burden.
罕见病(RDs)是沙特阿拉伯等高血缘关系地区的主要公共卫生挑战。它们大多是遗传性的、慢性的,缺乏有效的治疗,常常面临诊断延误和有限的护理。本研究系统地回顾了沙特阿拉伯rd的患病率、遗传风险因素和医疗挑战。方法按照PRISMA 2020指南进行系统评价。检索的数据库包括MEDLINE (PubMed)、Embase、Web of Science和Scopus(2014-2024)。符合条件的研究涉及沙特阿拉伯RDs的流行病学、遗传易感性或临床管理。提取的数据包括研究设计、样本量、疾病类型和结果。采用乔安娜布里格斯研究所(JBI)工具评估研究质量。结果597项记录中,25项研究符合纳入标准。常见的rd是杜氏肌营养不良(DMD)、特发性肺纤维化(IPF)、重症肌无力(MG)、肉芽肿伴多血管炎(GPA)、镰状细胞病(SCD)和脊髓性肌萎缩(SMA)。在所有研究中,延迟诊断、缺乏遗传筛查和高经济负担是一致的主题。高血缘关系增加常染色体隐性遗传病。主要差距包括获得专业护理、先进疗法的机会有限,以及缺乏国家RD登记。结论沙特阿拉伯迫切需要扩大遗传筛查,提高诊断水平,加强RD保健服务。建立登记、提高认识和开发具有成本效益的疗法对于改善结果和减轻疾病负担至关重要。
{"title":"Understanding rare diseases in Saudi Arabia: A systematic review of available evidence","authors":"Dalal Alkathiry ,&nbsp;Mohammed Alabdulaali ,&nbsp;Ghali Sayedahmed ,&nbsp;Anas Almasud ,&nbsp;Nora Althumairi ,&nbsp;Guillaume Favier ,&nbsp;Abdulelah AlGosaibi ,&nbsp;Karam Rachid ,&nbsp;Norah AlMousa ,&nbsp;Haya Intabli ,&nbsp;Mohammed Senitan ,&nbsp;Nawfal Aljerian","doi":"10.1016/j.humgen.2026.201534","DOIUrl":"10.1016/j.humgen.2026.201534","url":null,"abstract":"<div><h3>Introduction</h3><div>Rare diseases (RDs) are a major public health challenge in high-consanguinity regions like Saudi Arabia. Mostly genetic, chronic, and lacking effective treatment, they often face diagnostic delays and limited care. This study systematically reviews the prevalence, genetic risk factors, and healthcare challenges of RDs in Saudi Arabia.</div></div><div><h3>Methods</h3><div>A systematic review was conducted following PRISMA 2020 guidelines. Databases searched included MEDLINE (PubMed), Embase, Web of Science, and Scopus (2014–2024). Eligible studies addressed epidemiology, genetic predisposition, or clinical management of RDs in Saudi Arabia. Extracted data covered study design, sample size, disease type, and findings. Study quality was assessed with the Joanna Briggs Institute (JBI) tool.</div></div><div><h3>Results</h3><div>From 597 records, 25 studies met inclusion. Frequently studied RDs were Duchenne Muscular Dystrophy (DMD), Idiopathic Pulmonary Fibrosis (IPF), Myasthenia Gravis (MG), Granulomatosis with Polyangiitis (GPA), Sickle Cell Disease (SCD), and Spinal Muscular Atrophy (SMA). Across studies, delayed diagnosis, lack of genetic screening, and high economic burden were consistent themes. High consanguinity increased autosomal recessive disorders. Major gaps included limited access to specialized care, advanced therapies, and the absence of a national RD registry.</div></div><div><h3>Conclusions</h3><div>There is urgent need to expand genetic screening, improve diagnostics, and strengthen RD healthcare services in Saudi Arabia. Establishing registries, raising awareness, and developing cost-effective therapies are critical to improving outcomes and reducing disease burden.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201534"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146173025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring non -coding RNAs contribution to neural tube defects 探索非编码rna在神经管缺陷中的作用
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2026-01-05 DOI: 10.1016/j.humgen.2025.201528
Zahraa Isam Jameel
This review paper covers the diversified role of non-coding RNAs (ncRNAs) in the formation of neural tube defects (NTDs). NTDs are a group of serious birth defects that arise when the neural tube does not close normally during the early embryonic development. Although both genetic and environmental factors are known to cause neural tube defects (NTDs), the role of non-coding RNAs (ncRNAs) in the molecular mechanisms is becoming more evident. In this article, the different kinds of ncRNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), and their particular roles during neural tube closure will be discussed, focusing on their prospects as therapeutic targets for NTD prevention or treatment. Studies have revealed the role of specific microRNAs, such as members in the miR-17–92 and miR-100 clusters, in the regulation of essential processes, including the proliferation, differentiation, and death of neural precursor cells. The disruption of critical signaling, such as folate metabolism and planar cell polarity, affects these processes. Moreover, there has now become evidence on the role of lncRNAs and circRNAs in the interaction with chromatin-modification complexes, influencing the epigenetic profiles required during neural tube closure, and the regulation of gene expression through the ceRNA action. The developing embryo, whose ncRNA network has the disrupted ncRNA network, has an increased risk of developing the defects in the neural tubes. conclusion, NTD ncRNs represent an important area in the understanding and diagnosis of neural tube defects. The use of ncRNs, particularly some types of microRNs, long ncRNs, and circRNs, has proven that they are far from the “noise” transcribed in the genome. In fact, they play vital roles in the regulation of genes related to the closing of the neural tube. When ncRNs, including some microRNs, long ncRNs, and circRNs, malfunction, they disrupt vital signaling, resulting in an increased risk of the development of NTDs in the embryo. ncRNs link genetic risk and environment, contributing to the increased incidence that was unaccounted for. Future studies, therefore, shall focus on the use of ncRNs in the biomarkers needed in detecting the risk factors and risk of NTDs, the use of long ncRNs and circRNs, and the development of strategies in the prevention of congenital defects.
本文综述了非编码rna (ncRNAs)在神经管缺陷(NTDs)形成中的多种作用。ntd是一组严重的出生缺陷,当神经管在早期胚胎发育期间不能正常关闭时出现。虽然已知遗传和环境因素都可导致神经管缺陷(NTDs),但非编码rna (ncRNAs)在分子机制中的作用越来越明显。本文将讨论不同种类的ncRNAs,如microRNAs (miRNAs)、长链非编码rna (lncRNAs)和环状rna (circRNAs),以及它们在神经管闭合过程中的特殊作用,重点讨论它们作为NTD预防或治疗的治疗靶点的前景。研究揭示了特定的microrna,如miR-17-92和miR-100簇中的成员,在调节基本过程中的作用,包括神经前体细胞的增殖、分化和死亡。关键信号的破坏,如叶酸代谢和平面细胞极性,影响这些过程。此外,目前已有证据表明lncrna和circrna与染色质修饰复合物相互作用,影响神经管闭合过程中所需的表观遗传谱,并通过ceRNA作用调节基因表达。发育中的胚胎,其ncRNA网络有被破坏的ncRNA网络,在神经管中发生缺陷的风险增加。结论NTD ncrn是神经管缺损认识和诊断的重要领域。ncrn的使用,特别是某些类型的microrn、long ncrn和circrn,已经证明它们与基因组转录的“噪音”相去甚远。事实上,它们在调节与神经管闭合相关的基因中起着至关重要的作用。当ncrn,包括一些microrn、long ncrn和circrn发生故障时,它们会破坏生命信号,导致胚胎中ntd发育的风险增加。ncrn将遗传风险和环境联系起来,导致了未被解释的发病率增加。因此,未来的研究应侧重于ncrn在检测ntd危险因素和风险所需的生物标志物中的应用,长ncrn和环状ncrn的使用,以及先天性缺陷预防策略的制定。
{"title":"Exploring non -coding RNAs contribution to neural tube defects","authors":"Zahraa Isam Jameel","doi":"10.1016/j.humgen.2025.201528","DOIUrl":"10.1016/j.humgen.2025.201528","url":null,"abstract":"<div><div>This review paper covers the diversified role of non-coding RNAs (ncRNAs) in the formation of neural tube defects (NTDs). NTDs are a group of serious birth defects that arise when the neural tube does not close normally during the early embryonic development. Although both genetic and environmental factors are known to cause neural tube defects (NTDs), the role of non-coding RNAs (ncRNAs) in the molecular mechanisms is becoming more evident. In this article, the different kinds of ncRNAs, such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), and their particular roles during neural tube closure will be discussed, focusing on their prospects as therapeutic targets for NTD prevention or treatment. Studies have revealed the role of specific microRNAs, such as members in the miR-17–92 and miR-100 clusters, in the regulation of essential processes, including the proliferation, differentiation, and death of neural precursor cells. The disruption of critical signaling, such as folate metabolism and planar cell polarity, affects these processes. Moreover, there has now become evidence on the role of lncRNAs and circRNAs in the interaction with chromatin-modification complexes, influencing the epigenetic profiles required during neural tube closure, and the regulation of gene expression through the ceRNA action. The developing embryo, whose ncRNA network has the disrupted ncRNA network, has an increased risk of developing the defects in the neural tubes. conclusion, NTD ncRNs represent an important area in the understanding and diagnosis of neural tube defects. The use of ncRNs, particularly some types of microRNs, long ncRNs, and circRNs, has proven that they are far from the “noise” transcribed in the genome. In fact, they play vital roles in the regulation of genes related to the closing of the neural tube. When ncRNs, including some microRNs, long ncRNs, and circRNs, malfunction, they disrupt vital signaling, resulting in an increased risk of the development of NTDs in the embryo. ncRNs link genetic risk and environment, contributing to the increased incidence that was unaccounted for. Future studies, therefore, shall focus on the use of ncRNs in the biomarkers needed in detecting the risk factors and risk of NTDs, the use of long ncRNs and circRNs, and the development of strategies in the prevention of congenital defects.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201528"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondrial ND3, tRNA (Leu) and hypervariable region I: Variants in type II diabetes patients from the central rural Indian population. 线粒体ND3、tRNA (Leu)和高变区I:印度中部农村人口II型糖尿病患者的变异
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2025-11-29 DOI: 10.1016/j.humgen.2025.201520
Tejas Tajane , Mamata Chandrakar , Prafulla Ambulkar , Pranita Waghmare , Bharati Taksande , Jwalant Waghmare
Diabetes is a lifestyle disorder with the highest mortality rate, and mitochondria play a crucial role in the susceptibility and severity of diabetes. This study examined the relationship between mitochondrial genomic variants and lifestyle factors in patients with type 2 diabetes (T2D) within a rural central Indian population. We enrolled 156 participants with diabetes and 108 healthy participants, analysing their anthropometric measurements, lifestyle habits, and mitochondrial DNA (mtDNA) variants. A total of 74 variants were identified, with the D-loop region showing the highest mutation rates. When correlated with BMI, waist-to-hip ratio, and sedentary behaviour, these factors were significantly higher in the diabetes group than in the control group. The variants A10398G and C10400T in ND3 and C16223T in the D-loop were significantly associated with T2D, while T16093C and A3384G were more common in healthy controls, indicating a protective role. Analysing haplogroups revealed that the M haplogroup was the most prevalent, followed by U and H, with H being significantly more common in the healthy group. Additionally, lifestyle factors such as a high-carbohydrate diet and tobacco use contributed to disease progression. This study underscores that certain novel variants are linked to decreased susceptibility to T2D and highlights the complex interaction between mtDNA variants, lifestyle factors, and T2D in the Indian population.
糖尿病是一种死亡率最高的生活方式疾病,线粒体在糖尿病的易感性和严重程度中起着至关重要的作用。本研究调查了印度中部农村人口中2型糖尿病(T2D)患者线粒体基因组变异与生活方式因素之间的关系。我们招募了156名糖尿病患者和108名健康参与者,分析了他们的人体测量值、生活习惯和线粒体DNA (mtDNA)变异。共鉴定出74个变异,其中D-loop区域的突变率最高。当与身体质量指数、腰臀比和久坐行为相关时,糖尿病组的这些因素明显高于对照组。ND3中的A10398G和C10400T以及D-loop中的C16223T变异与T2D显著相关,而T16093C和A3384G在健康对照中更为常见,表明其具有保护作用。单倍群分析显示,M单倍群最为普遍,其次是U和H,其中H在健康人群中更为常见。此外,高碳水化合物饮食和吸烟等生活方式因素也会导致疾病进展。这项研究强调了某些新的变异与T2D易感性降低有关,并强调了mtDNA变异、生活方式因素和印度人群中T2D之间复杂的相互作用。
{"title":"Mitochondrial ND3, tRNA (Leu) and hypervariable region I: Variants in type II diabetes patients from the central rural Indian population.","authors":"Tejas Tajane ,&nbsp;Mamata Chandrakar ,&nbsp;Prafulla Ambulkar ,&nbsp;Pranita Waghmare ,&nbsp;Bharati Taksande ,&nbsp;Jwalant Waghmare","doi":"10.1016/j.humgen.2025.201520","DOIUrl":"10.1016/j.humgen.2025.201520","url":null,"abstract":"<div><div>Diabetes is a lifestyle disorder with the highest mortality rate, and mitochondria play a crucial role in the susceptibility and severity of diabetes. This study examined the relationship between mitochondrial genomic variants and lifestyle factors in patients with type 2 diabetes (T2D) within a rural central Indian population. We enrolled 156 participants with diabetes and 108 healthy participants, analysing their anthropometric measurements, lifestyle habits, and mitochondrial DNA (mtDNA) variants. A total of 74 variants were identified, with the D-loop region showing the highest mutation rates. When correlated with BMI, waist-to-hip ratio, and sedentary behaviour, these factors were significantly higher in the diabetes group than in the control group. The variants A10398G and C10400T in ND3 and C16223T in the D-loop were significantly associated with T2D, while T16093C and A3384G were more common in healthy controls, indicating a protective role. Analysing haplogroups revealed that the M haplogroup was the most prevalent, followed by U and H, with H being significantly more common in the healthy group. Additionally, lifestyle factors such as a high-carbohydrate diet and tobacco use contributed to disease progression. This study underscores that certain novel variants are linked to decreased susceptibility to T2D and highlights the complex interaction between mtDNA variants, lifestyle factors, and T2D in the Indian population.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201520"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of DVWA (rs7639618) gene polymorphisms with knee osteoarthritis susceptibility: An updated systematic review and meta-analysis DVWA (rs7639618)基因多态性与膝骨关节炎易感性的关联:一项最新的系统综述和荟萃分析
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2025-11-28 DOI: 10.1016/j.humgen.2025.201519
Annamalai R , Venkatramanaiah C , Marimuthu Raja , Santhosh Kumar Yasam , Sujhithra A , Catherine Rexy , Vignesh Narasimman , D. Danis Vijay

Background & aim

Knee osteoarthritis (KOA)1 is a common degenerative joint disease characterized by progressive cartilage breakdown that leads to pain and reduced mobility. Although genetic predisposition including the double von Willebrand factor A (DVWA; rs7639618) gene polymorphism has been implicated in KOA, previous case–control studies have reported inconsistent findings. This updated meta-analysis aims to clarify the association between the DVWA (rs7639618) gene polymorphism and KOA susceptibility.

Materials & methods

A systematic search was performed in Pub Med, Web of Science, Science Direct, and Google Scholar for case–control studies published up to June 2025. Eligible studies reported genotype and allele distributions for rs7639618 in KOA cases and controls. Study quality was assessed using the Newcastle–Ottawa Scale (NOS).2 Odds ratios (ORs)3 with 95 % confidence intervals (CIs)4 were calculated under allele, recessive, dominant, and over-dominant models. Heterogeneity was evaluated using the Q test and I2 statistic, and random- or fixed-effects models were applied accordingly. Subgroup analyses were conducted by ethnicity, and publication bias was assessed with funnel plots and Egger's test. Sensitivity analysis was carried out by excluding each study.

Results

Thirteen studies comprising 7110 KOA cases and 6931 controls were included. Pooled analyses across all genetic models showed no statistically significant association between rs7639618 and KOA susceptibility. For the allele contrast model, the overall OR was 1.03 (95 % CI: 0.90–1.19); for the recessive model, OR was 1.06 (95 % CI: 0.90–1.25); for the dominant model, OR was 1.08 (95 % CI: 0.85–1.38); and for the over-dominant model, OR was 0.98 (95 % CI: 0.91–1.05). Subgroup analyses revealed no increased risk in either Asian or Caucasian populations. Sensitivity analysis confirmed the stability of the results, and no significant publication bias was detected.

Conclusion

The findings of this meta-analysis suggest that the DVWA (rs7639618) polymorphism is not significantly associated with KOA susceptibility in the overall population or within specific ethnic groups. Despite the rigorous methodology and comprehensive analysis, the presence of substantial heterogeneity in some genetic models underscores the need for further well-designed, large-scale studies across diverse populations.
膝关节骨关节炎(KOA)1是一种常见的退行性关节疾病,其特征是进行性软骨破裂,导致疼痛和活动能力降低。虽然包括双血管性血液病因子A (DVWA; rs7639618)基因多态性在内的遗传易感性与KOA有关,但先前的病例对照研究报告的结果不一致。这项更新的荟萃分析旨在阐明DVWA (rs7639618)基因多态性与KOA易感性之间的关系。材料&方法系统检索Pub Med、Web of Science、Science Direct和b谷歌Scholar,检索截至2025年6月发表的病例对照研究。符合条件的研究报告了rs7639618在KOA病例和对照组中的基因型和等位基因分布。采用纽卡斯尔-渥太华量表(NOS)评估研究质量在等位基因、隐性、显性和过显性模型下计算优势比(ORs)和95%置信区间(ci)。采用Q检验和I2统计量评估异质性,并相应采用随机或固定效应模型。按种族进行亚组分析,用漏斗图和Egger检验评估发表偏倚。通过排除每项研究进行敏感性分析。结果纳入13项研究,7110例KOA病例和6931例对照。所有遗传模型的汇总分析显示,rs7639618与KOA易感性之间没有统计学意义上的关联。对于等位基因对比模型,总体OR为1.03 (95% CI: 0.90-1.19);对于隐性模型,OR为1.06 (95% CI: 0.90-1.25);优势模型OR为1.08 (95% CI: 0.85-1.38);对于过优势模型,OR为0.98 (95% CI: 0.91-1.05)。亚组分析显示,无论是亚洲人还是高加索人,风险都没有增加。敏感性分析证实了结果的稳定性,未发现明显的发表偏倚。结论本荟萃分析结果提示,DVWA (rs7639618)多态性与KOA易感性在总体人群或特定族群中均无显著相关性。尽管有严格的方法和全面的分析,但在一些遗传模型中存在实质性的异质性,这强调了进一步在不同人群中进行精心设计的大规模研究的必要性。
{"title":"Association of DVWA (rs7639618) gene polymorphisms with knee osteoarthritis susceptibility: An updated systematic review and meta-analysis","authors":"Annamalai R ,&nbsp;Venkatramanaiah C ,&nbsp;Marimuthu Raja ,&nbsp;Santhosh Kumar Yasam ,&nbsp;Sujhithra A ,&nbsp;Catherine Rexy ,&nbsp;Vignesh Narasimman ,&nbsp;D. Danis Vijay","doi":"10.1016/j.humgen.2025.201519","DOIUrl":"10.1016/j.humgen.2025.201519","url":null,"abstract":"<div><h3>Background &amp; aim</h3><div>Knee osteoarthritis (KOA)<span><span><sup>1</sup></span></span> is a common degenerative joint disease characterized by progressive cartilage breakdown that leads to pain and reduced mobility. Although genetic predisposition including the double von Willebrand factor A (DVWA; rs7639618) gene polymorphism has been implicated in KOA, previous case–control studies have reported inconsistent findings. This updated meta-analysis aims to clarify the association between the DVWA (rs7639618) gene polymorphism and KOA susceptibility.</div></div><div><h3>Materials &amp; methods</h3><div>A systematic search was performed in Pub Med, Web of Science, Science Direct, and Google Scholar for case–control studies published up to June 2025. Eligible studies reported genotype and allele distributions for rs7639618 in KOA cases and controls. Study quality was assessed using the Newcastle–Ottawa Scale (NOS).<span><span><sup>2</sup></span></span> Odds ratios (ORs)<span><span><sup>3</sup></span></span> with 95 % confidence intervals (CIs)<span><span><sup>4</sup></span></span> were calculated under allele, recessive, dominant, and over-dominant models. Heterogeneity was evaluated using the Q test and I<sup>2</sup> statistic, and random- or fixed-effects models were applied accordingly. Subgroup analyses were conducted by ethnicity, and publication bias was assessed with funnel plots and Egger's test. Sensitivity analysis was carried out by excluding each study.</div></div><div><h3>Results</h3><div>Thirteen studies comprising 7110 KOA cases and 6931 controls were included. Pooled analyses across all genetic models showed no statistically significant association between rs7639618 and KOA susceptibility. For the allele contrast model, the overall OR was 1.03 (95 % CI: 0.90–1.19); for the recessive model, OR was 1.06 (95 % CI: 0.90–1.25); for the dominant model, OR was 1.08 (95 % CI: 0.85–1.38); and for the over-dominant model, OR was 0.98 (95 % CI: 0.91–1.05). Subgroup analyses revealed no increased risk in either Asian or Caucasian populations. Sensitivity analysis confirmed the stability of the results, and no significant publication bias was detected.</div></div><div><h3>Conclusion</h3><div>The findings of this meta-analysis suggest that the DVWA (rs7639618) polymorphism is not significantly associated with KOA susceptibility in the overall population or within specific ethnic groups. Despite the rigorous methodology and comprehensive analysis, the presence of substantial heterogeneity in some genetic models underscores the need for further well-designed, large-scale studies across diverse populations.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201519"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of key players in drug resistant colon cancer - An integrative network pharmacology approach 鉴定耐药结肠癌的关键因素-综合网络药理学方法
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2025-12-03 DOI: 10.1016/j.humgen.2025.201521
Jeevitha Priya Manoharan , Neha Saravanakumar , Hema Palanisamy , Subramanian Vidyalakshmi
Multi Drug Resistance (MDR) of cancer cells is the most important cause for the failure of chemotherapy in treating cancer patients. Hence, identification of appropriate drug resistance biomarkers is the need of the hour to optimize treatment regimen. The goal of this study is to identify critical genes and pathways that could be used to predict the drug resistance in colon cancer patients. In this study, gene expression datasets of colon cancer patients and cell lines treated with 5-fluorouracil, irinotecan and oxaliplatin were obtained. Differential gene expression analysis was performed and the hub genes associated with drug resistance were identified through network analysis. The functional and pathway enrichment of the genes were performed. ABCC4, AKR1C3, CASP3, CASP4, IFITM1, IFITM2, IFITM3, IFI6, IFI44, IFI16, IFI27 and SLC1A7 were found to be highly interacting (Hub) genes in the network analysis. Two significant modules were predicted in the generated network by module analysis. The genes of module 2 were observed to be highly interacting with each other in the pathway cross talk analysis. Among the identified genes, IFI44 was significantly associated with the patients' overall survival. In addition, IFI44 found to be associated with immune infiltration in the tumor microenvironment. In addition, B-cell receptor signalling pathway, galactose metabolism, steroid hormone biosynthesis and folate biosynthesis pathway can be targeted for improving the efficacy of chemotherapeutic drugs, while treating multidrug resistant colon cancer. Hence, IFI44 could be used as a biomarker for identifying drug resistance. Further, experimental studies are required to validate our findings.
肿瘤细胞的耐多药(MDR)是导致化疗失败的最重要原因。因此,确定适当的耐药生物标志物是优化治疗方案的需要。本研究的目的是确定可用于预测结肠癌患者耐药性的关键基因和途径。本研究获得了5-氟尿嘧啶、伊立替康和奥沙利铂治疗的结肠癌患者和细胞系的基因表达数据集。进行差异基因表达分析,通过网络分析鉴定与耐药相关的枢纽基因。对这些基因进行功能富集和途径富集。网络分析发现ABCC4、AKR1C3、CASP3、CASP4、IFITM1、IFITM2、IFITM3、IFI6、IFI44、IFI16、IFI27和SLC1A7是高互作(Hub)基因。通过模块分析,在生成的网络中预测出两个显著的模块。在通路串扰分析中,发现模块2的基因之间存在高度相互作用。在已鉴定的基因中,IFI44与患者的总生存率显著相关。此外,发现IFI44与肿瘤微环境中的免疫浸润有关。此外,b细胞受体信号通路、半乳糖代谢、类固醇激素生物合成和叶酸生物合成途径可以作为提高化疗药物疗效的靶点,同时治疗多重耐药结肠癌。因此,IFI44可作为鉴定耐药的生物标志物。此外,还需要实验研究来验证我们的发现。
{"title":"Identification of key players in drug resistant colon cancer - An integrative network pharmacology approach","authors":"Jeevitha Priya Manoharan ,&nbsp;Neha Saravanakumar ,&nbsp;Hema Palanisamy ,&nbsp;Subramanian Vidyalakshmi","doi":"10.1016/j.humgen.2025.201521","DOIUrl":"10.1016/j.humgen.2025.201521","url":null,"abstract":"<div><div>Multi Drug Resistance (MDR) of cancer cells is the most important cause for the failure of chemotherapy in treating cancer patients. Hence, identification of appropriate drug resistance biomarkers is the need of the hour to optimize treatment regimen. The goal of this study is to identify critical genes and pathways that could be used to predict the drug resistance in colon cancer patients. In this study, gene expression datasets of colon cancer patients and cell lines treated with 5-fluorouracil, irinotecan and oxaliplatin were obtained. Differential gene expression analysis was performed and the hub genes associated with drug resistance were identified through network analysis. The functional and pathway enrichment of the genes were performed. ABCC4, AKR1C3, CASP3, CASP4, IFITM1, IFITM2, IFITM3, IFI6, IFI44, IFI16, IFI27 and SLC1A7 were found to be highly interacting (Hub) genes in the network analysis. Two significant modules were predicted in the generated network by module analysis. The genes of module 2 were observed to be highly interacting with each other in the pathway cross talk analysis. Among the identified genes, IFI44 was significantly associated with the patients' overall survival. In addition, IFI44 found to be associated with immune infiltration in the tumor microenvironment. In addition, B-cell receptor signalling pathway, galactose metabolism, steroid hormone biosynthesis and folate biosynthesis pathway can be targeted for improving the efficacy of chemotherapeutic drugs, while treating multidrug resistant colon cancer. Hence, IFI44 could be used as a biomarker for identifying drug resistance. Further, experimental studies are required to validate our findings.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201521"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Parkinson's disease: Insights from genetic biomarkers and protein-protein interactions 探索帕金森病:来自遗传生物标志物和蛋白质-蛋白质相互作用的见解
IF 0.7 Q4 GENETICS & HEREDITY Pub Date : 2026-02-01 Epub Date: 2025-12-08 DOI: 10.1016/j.humgen.2025.201523
Zahra Parani , Yeganeh Sorayaei , Mohammad Shokrzadeh , Nargess Abdali , Elham Rismani
Parkinson's disease (PD) ranks as the second most prevalent neurodegenerative disorder, primarily characterized by motor dysfunction resulting from the degeneration of dopaminergic neurons. Early and accurate diagnosis is crucial for effective treatment; however, the overlap of symptoms with other disorders frequently results in misdiagnosis. This study aims to identify reliable biomarkers for the early PD diagnosis through a comprehensive literature review and bioinformatics analysis. We initially identified 32 genes strongly associated with PD, from published studies and database annotations. Further bioinformatics validation using protein-protein interaction networks and external gene expression datasets revealed additional candidate genes, including GBA1 and LRRK2, which are relevant to both familial and sporadic forms of PD. Enrichment analyses of these genes, emphasizing pathways related to mitochondrial function, autophagy and neurodegeneration-related pathways. Our findings highlight the promise of genetic biomarkers in improving diagnostic precision and guiding therapeutic approaches, thereby enhancing clinical outcomes for patients with PD. Ongoing validation of these results is essential for integrating biomarkers into standard clinical practice, with the ultimate goal of revolutionizing the diagnosis and management of PD.
帕金森病(PD)是第二大常见的神经退行性疾病,主要特征是多巴胺能神经元变性导致的运动功能障碍。早期和准确的诊断对于有效治疗至关重要;然而,症状与其他疾病的重叠经常导致误诊。本研究旨在通过全面的文献综述和生物信息学分析,寻找可靠的PD早期诊断的生物标志物。我们最初从已发表的研究和数据库注释中确定了32个与帕金森病密切相关的基因。利用蛋白相互作用网络和外部基因表达数据集进一步的生物信息学验证揭示了其他候选基因,包括GBA1和LRRK2,它们与家族性和散发性PD相关。富集分析这些基因,强调与线粒体功能、自噬和神经变性相关的途径。我们的研究结果强调了遗传生物标志物在提高诊断精度和指导治疗方法方面的前景,从而提高了PD患者的临床结果。这些结果的持续验证对于将生物标志物纳入标准临床实践至关重要,最终目标是彻底改变PD的诊断和管理。
{"title":"Exploring Parkinson's disease: Insights from genetic biomarkers and protein-protein interactions","authors":"Zahra Parani ,&nbsp;Yeganeh Sorayaei ,&nbsp;Mohammad Shokrzadeh ,&nbsp;Nargess Abdali ,&nbsp;Elham Rismani","doi":"10.1016/j.humgen.2025.201523","DOIUrl":"10.1016/j.humgen.2025.201523","url":null,"abstract":"<div><div>Parkinson's disease (PD) ranks as the second most prevalent neurodegenerative disorder, primarily characterized by motor dysfunction resulting from the degeneration of dopaminergic neurons. Early and accurate diagnosis is crucial for effective treatment; however, the overlap of symptoms with other disorders frequently results in misdiagnosis. This study aims to identify reliable biomarkers for the early PD diagnosis through a comprehensive literature review and bioinformatics analysis. We initially identified 32 genes strongly associated with PD, from published studies and database annotations. Further bioinformatics validation using protein-protein interaction networks and external gene expression datasets revealed additional candidate genes, including GBA1 and LRRK2, which are relevant to both familial and sporadic forms of PD. Enrichment analyses of these genes, emphasizing pathways related to mitochondrial function, autophagy and neurodegeneration-related pathways. Our findings highlight the promise of genetic biomarkers in improving diagnostic precision and guiding therapeutic approaches, thereby enhancing clinical outcomes for patients with PD. Ongoing validation of these results is essential for integrating biomarkers into standard clinical practice, with the ultimate goal of revolutionizing the diagnosis and management of PD.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"47 ","pages":"Article 201523"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Human Gene
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1